Navigation Links
Cancer Patients in New South Wales to Receive Advanced Image Guided Radiation Therapy Treatments

North Coast Cancer Institute (NCCI) Coffs Harbour and Port Macquarie began providing radiotherapy treatment services for the first time in the North Coast region of New South Wales, Australia .

Cancer patients in New South Wales now have access to state-of-the-art treatments as the latest in image-guided radiation therapy ( IGRT) equipment from Elekta went clinical at both sites. The first treatment was a major step for a small centre introducing complex treatment technologies such as IMRT and IGRT on an Elekta Synergy(R) system advanced digital linear accelerator, supported by IMPAC MOSAIQ(TM) Oncology information system. The first patient treated had intermediate risk prostate cancer and was planned with MRI-CT fusion and fiducial marker insertion, and treated with dose-escalated 7-field IMRT with online cone-beam CT and electronic portal image verification.

"As a result of the technology now available at the NCCI, we will be able to provide patients with the most modern, highest quality radiation oncology treatment available in Australia," said Area Director of Cancer Services A. Prof. Tom Shakespeare. "What's really exciting is seeing this ground-breaking technology made available to smaller regional centres that have, until now, had no local access to radiotherapy. Even more impressive, is the fact that our team has been able to implement complex Intensity Modulated Radiotherapy Treatment modalities and adopt image guided treatment techniques from the start. This was accomplished in order to offer patients the highest possible quality of care. With the incredible support provided by Elekta, Coffs Harbour has evolved from a city without radiotherapy to a city with the highest quality radiotherapy in the region and our Port Macquarie centre also will start soon, offering the same impressive treatment capabilities. It is not surprising that we are now receiving referrals from across the state and even interstate."

Elekta Sy nergy was selected for the NCCI following a competitive tender process and is considered the market-leading IGRT solution, revolutionizing radiotherapy by offering integrated 3D volumetric imaging at the time of treatment. By imaging patients in the treatment position during the actual time of treatment, Elekta Synergy is able to offer significantly greater treatment accuracy and higher confidence that the intended therapeutic dose is delivered to the patient as planned.


'"/>




Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... 26, 2016 , ... Dr. James Maisel will present on ... Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public Library. The ... Group of New York , is a Board Certified ophthalmologist who completed his ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of Life Science Logistics ... organization has earned its ISO 13485 certification, indicating the company’s quality control system ... and policies associated with ISO quality standard 13485. , BSI Group America, ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... multitude of activities from daily practices, arts & crafts, discussions, and games all ... East-D’Anna and Christy Evans have combined backgrounds in kids’ yoga, collegiate sport yoga ...
(Date:5/26/2016)... ... 26, 2016 , ... Power Systems, a leading developer and ... Certification Course in Stoughton, Massachusetts. The course was led by Power Systems’ Education ... hour interactive course to qualify participants as certified PowerWave trainers. , PowerWave ...
(Date:5/26/2016)... ... ... A health conscious snack that doesn't sacrifice taste? It's possible! In one ... buzz in the protein product community by offering an alternative to the traditional bar ... with 11 grams of protein and made from a healthy blend of high quality ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... NEW YORK , May 25, 2016 ... Device Market Size, Share, Development, Growth and Demand Forecast ... Insulin Syringe, Insulin Pump and Others)" published by P&S ... valued at $9,998.3 million in 2015, and it is ... 2016-2022. Based on type, the insulin pump segment is ...
Breaking Medicine Technology: